激酶是一种将磷酸基团添加到底物分子上的酶，这个过程被称为磷酸化。蛋白磷酸化是调控细胞分裂、代谢、信号转导等大量细胞过程的关键环节。在人类基因组中，至少可以编码 500 多种激酶，其中大约有 50% 的细胞功能受激酶调控。激酶是新药开发中的一大类靶点。激酶抑制剂是一类重要的药物，可阻断某些与疾病相关的酶的活性，如癌症和炎症性疾病。
Chem960 激酶抑制剂库包含激酶抑制剂，主要靶向对蛋白激酶 (VEGFR、EGFR、BTK、CDK、Ak t等)、脂质激酶 (PI3K、PI4K、SK 等) 和碳水化合物激酶 (己糖激酶) 。是激酶药物开发及相关研究的有用工具。
• A unique collection of 1274 phosphorylation kinase inhibitors/regulators for high throughput screening (HTS) and high content screening (HCS).
• The library contains compounds targeting protein kinases (VEGFR, EGFR, BTK, CDK, Akt, etc.), lipid kinases (PI3K, PI4K, SK, etc.) and carbohydrate kinases (Hexokinase).
• Kinase inhibitors have played an increasingly prominent role in the treatment of cancer and other diseases.
• Bioactivity and safety confirmed by preclinical research and clinical trials. Some inhibitors have been approved by FDA.
• Structurally diverse, medicinally active, and cell permeable.
• Rich documentation with structure, IC50, and customer reviews.
• NMR and HPLC validated to ensure high purity.
• All compounds are in stock and continuously updated.
